LiquidPlex™ is an advanced and user-friendly solution for targeted next-generation sequencing (NGS) of circulating cell-free tumor DNA (ccfDNA/cfDNA/ctDNA) from 28 genes commonly associated with solid tumor type cancers. LiquidPlex uses Anchored Multiplex PCR (AMP™) enrichment chemistry, in which DNA fragments are ligated to molecular barcodes (MBCs) that enable error correction for confident variant reporting.
Solid Tumor
AKT1 (V-akt murine thymoma viral oncogene homolog 1), ALK (Anaplastic lymphoma kinase), AR (Androgen receptor), BRAF (B-raf proto-oncogene), CTNNB1 (Catenin (cadherin-associated protein), beta 1), DDR2 (Discoidin domain receptor 2)
See More ...
Next-Generation Sequencing (NGS)